There’s a gene therapy coming out that could be like a cure for sickle cell. Costs for this type of medicine for other diseases are running into the millions.
ADVISORY: Cancer Patient David Mitchell to Address National Academy of Medicine Conference on Thursday
Two-Day Workshop Examines NIH’s Role in Drug Development and Pricing.
We need laws in place that will allow all patients, regardless of background, to have access to life-saving medication.
American Taxpayers invested hundreds of millions of dollars into a gene therapy to cure sickle cell disease; now a drug company is likely to make billions and price it out of reach.
New data show how negotiating for the 250 most-expensive drugs could save patients, taxpayers billions.